LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Rescue Treatment with Infliximab for a Bilateral, Severe, Sight Threatening Frosted Branch Angiitis Associated with Concomitant Acute Onset of Presumed Dermatomyositis

Photo by geraninmo from unsplash

ABSTRACT Purpose To report a severe bilateral frosted branch angiitis associated with acute onset of systemic dermatomyositis. Method History and clinical examination, laboratory evaluation, fundus’ and skin’s color pictures, fluorescein… Click to show full abstract

ABSTRACT Purpose To report a severe bilateral frosted branch angiitis associated with acute onset of systemic dermatomyositis. Method History and clinical examination, laboratory evaluation, fundus’ and skin’s color pictures, fluorescein angiography (FA), optical coherence tomography (OCT). Results A 32-year-old female was referred for a bilateral frosted branch angiitis and vitreitis, with skin rash, muscle pain, weakness, severe headache, compatible with dermatomyositis. After an initial improvement following an aggressive treatment by systemic steroids and mycophenolate mofetil, she was switched to intravenous infliximab (RemicadeTM, Janssen Biotech, Inc. USA) due to lack of efficacy. Nine months later, her visual acuity was improved up to 20/20 in OU, with both retinal vasculitis and vitreitis being solved. Conclusion Dermatomyositis is a severe multiorgan disease which might severely involve eye structures. Anti-TNF-Alpha agents, particularly Infliximab, might offer a rapid control and long-term remission.

Keywords: angiitis associated; frosted branch; branch angiitis; dermatomyositis

Journal Title: Ocular Immunology and Inflammation
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.